Search
Search Constraints
You searched for: Author/Creator Sheldon, EricLimit your search
- Sheldon, Eric [remove] 8
- 615.372 4
- Vaccines -- Periodicals 4
- 530 2
- Physics -- Periodicals 2
- 615.5 1
- 616.9 1
- AE adverse event -- AESI adverse event of specific interest -- AS adjuvant system -- CBER Center for Biologics Evaluation and Research -- CHMP Committee for Medicinal Products for Human Use -- CI confidence interval -- EMA European Medicines Agency -- GMT geometric mean titer -- HA hemagglutinin -- HI hemagglutination inhibition -- LL lower limit -- MAE medically-attended adverse event -- MGI mean geometric increase -- MN microneutralization -- pIMD potential immune-mediated disease -- PP per-protocol -- SAE serious adverse event -- SCR seroconversion rate -- SPR seroprotection rate -- UL upper limit -- US United States -- VRR vaccine response rate -- VVP groups receiving 2 vaccine doses + placebo -- VVV groups receiving 3 vaccine doses 1
- AE adverse event -- CBER Center for Biologics Evaluation and Research -- CHMP Committee for Medical Products for Human Use -- CI confidence interval -- GMT geometric mean titers -- HA hemagglutinin -- HI hemagglutination-inhibition -- MGI mean geometric increase -- MN microneutralization -- pIMD potential immune-mediated disease -- PP per-protocol -- RBC red blood cells -- SAE serious adverse event -- SAS statistical analysis system -- SBIR internet-based randomization system -- SCR seroconversion rate -- SPR seroprotection rate -- TVC total vaccinated cohort -- VRR vaccine response rate 1
- Al(OH)3 aluminum hydroxide -- C. difficile Clostridium difficile -- CDI Clostridium difficile infection -- PCR polymerase chain reaction 1
- Antibody -- Anti-IgE -- Atopic -- High-affinity -- IgE -- MEDI4212 -- Monoclonal -- Omalizumab 1